Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

NCT02874430 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped study closed early due to slow accrual

Conditions

Breast Carcinoma
Endometrial Clear Cell Adenocarcinoma
Endometrial Serous Adenocarcinoma
Uterine Corpus Cancer
Uterine Corpus Carcinosarcoma

Interventions

DRUG: Metformin Hydrochloride
DRUG: Doxycycline

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University